Conjunctival autograft with fibrin glue in primary pterygium Demographic profile, visual, refractive and surgical outcome

---

Original Article

Author Details : Soma Rani Roy*, Sujit Kumar Biswas, Fahmida Huque, Md. Sazzad Kader

Volume : 9, Issue : 2, Year : 2023

Article Page : 77-81

https://doi.org/10.18231/j.ijooo.2023.015

Suggest article by email

Get Permission

---

Abstract

Aim: To compare the pre and post-operative visual, refractive and surgical outcome.
Materials and Methods: It was a prospective interventional study of 56 primary pterygium patients with 12 months follow up. All patients underwent surgery with pterygium excision and conjunctival autograft fixation with fibrin glue without any fixating suture and adjuvant. Pre and post- operative visual acuity, spherical equivalent was compared and surgical outcome were evaluated. All patients were followed up to 12 months.
Result: The mean age was 42.43 ±13.38 years with male predominance. Seventy five percent (n=42) patients with normal vision (6/5 to 6/12, according to WHO) became 96% (n=54), 4 week post-operatively. Preoperatively, 42.8% (n=24) patients had spherical equivalent up to 1 D followed by 25% (n=14) Plano, 17.9% (n=10) up to 2 D, 5.4% (n=3) up to 3 D, 3.6% (n=2) had more than 3D which post operatively became 57.1% (n=32) up to 1D, 26.8% (n=15) Plano, 12.5% (n=7) up to 2D and there was no patients more than 2D with pre and post-operative comparison, p value of 0.000. There were no recurrence in 12 months follow up.
Conclusion: Fibrin glue is very much effective in reducing recurrence rate and minimizes the complication with a very good visual outcome within 4 week postoperatively if surgery done carefully.
 
Keywords: Pterygium, Fibrin glue, Spherical equivalent, Free conjunctival autograft, Recurrence

How to cite : Roy S R, Biswas S K, Huque F, Kader M S, Conjunctival autograft with fibrin glue in primary pterygium Demographic profile, visual, refractive and surgical outcome. IP Int J Ocul Oncol Oculoplasty 2023;9(2):77-81

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.